Cargando…
Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation
Persister cell formation and biofilms of pathogens are extensively involved in the development of chronic infectious diseases. Eradicating persister cells is challenging, owing to their tolerance to conventional antibiotics, which cannot kill cells in a metabolically dormant state. A high frequency...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Microbiology and Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513074/ https://www.ncbi.nlm.nih.gov/pubmed/33046677 http://dx.doi.org/10.4014/jmb.2008.08027 |
_version_ | 1784583145279979520 |
---|---|
author | Jin, Xing Zhou, Jiacheng Richey, Gabriella Wang, Mengya Hong, Sung Min Choi Hong, Seok Hoon |
author_facet | Jin, Xing Zhou, Jiacheng Richey, Gabriella Wang, Mengya Hong, Sung Min Choi Hong, Seok Hoon |
author_sort | Jin, Xing |
collection | PubMed |
description | Persister cell formation and biofilms of pathogens are extensively involved in the development of chronic infectious diseases. Eradicating persister cells is challenging, owing to their tolerance to conventional antibiotics, which cannot kill cells in a metabolically dormant state. A high frequency of persisters in biofilms makes inactivating biofilm cells more difficult, because the biofilm matrix inhibits antibiotic penetration. Fatty acids may be promising candidates as antipersister or antibiofilm agents, because some fatty acids exhibit antimicrobial effects. We previously reported that fatty acid ethyl esters effectively inhibit Escherichia coli persister formation by regulating an antitoxin. In this study, we screened a fatty acid library consisting of 65 different fatty acid molecules for altered persister formation. We found that undecanoic acid, lauric acid, and N-tridecanoic acid inhibited E. coli BW25113 persister cell formation by 25-, 58-, and 44-fold, respectively. Similarly, these fatty acids repressed persisters of enterohemorrhagic E. coli EDL933. These fatty acids were all medium-chain saturated forms. Furthermore, the fatty acids repressed Enterohemorrhagic E. coli (EHEC) biofilm formation (for example, by 8-fold for lauric acid) without having antimicrobial activity. This study demonstrates that medium-chain saturated fatty acids can serve as antipersister and antibiofilm agents that may be applied to treat bacterial infections. |
format | Online Article Text |
id | pubmed-8513074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Korean Society for Microbiology and Biotechnology |
record_format | MEDLINE/PubMed |
spelling | pubmed-85130742021-10-13 Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation Jin, Xing Zhou, Jiacheng Richey, Gabriella Wang, Mengya Hong, Sung Min Choi Hong, Seok Hoon J Microbiol Biotechnol Research article Persister cell formation and biofilms of pathogens are extensively involved in the development of chronic infectious diseases. Eradicating persister cells is challenging, owing to their tolerance to conventional antibiotics, which cannot kill cells in a metabolically dormant state. A high frequency of persisters in biofilms makes inactivating biofilm cells more difficult, because the biofilm matrix inhibits antibiotic penetration. Fatty acids may be promising candidates as antipersister or antibiofilm agents, because some fatty acids exhibit antimicrobial effects. We previously reported that fatty acid ethyl esters effectively inhibit Escherichia coli persister formation by regulating an antitoxin. In this study, we screened a fatty acid library consisting of 65 different fatty acid molecules for altered persister formation. We found that undecanoic acid, lauric acid, and N-tridecanoic acid inhibited E. coli BW25113 persister cell formation by 25-, 58-, and 44-fold, respectively. Similarly, these fatty acids repressed persisters of enterohemorrhagic E. coli EDL933. These fatty acids were all medium-chain saturated forms. Furthermore, the fatty acids repressed Enterohemorrhagic E. coli (EHEC) biofilm formation (for example, by 8-fold for lauric acid) without having antimicrobial activity. This study demonstrates that medium-chain saturated fatty acids can serve as antipersister and antibiofilm agents that may be applied to treat bacterial infections. Korean Society for Microbiology and Biotechnology 2021-01-28 2020-10-13 /pmc/articles/PMC8513074/ /pubmed/33046677 http://dx.doi.org/10.4014/jmb.2008.08027 Text en Copyright © 2021 by The Korean Society for Microbiology and Biotechnology https://creativecommons.org/licenses/by/4.0/This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research article Jin, Xing Zhou, Jiacheng Richey, Gabriella Wang, Mengya Hong, Sung Min Choi Hong, Seok Hoon Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation |
title | Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation |
title_full | Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation |
title_fullStr | Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation |
title_full_unstemmed | Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation |
title_short | Undecanoic Acid, Lauric Acid, and N-Tridecanoic Acid Inhibit Escherichia coli Persistence and Biofilm Formation |
title_sort | undecanoic acid, lauric acid, and n-tridecanoic acid inhibit escherichia coli persistence and biofilm formation |
topic | Research article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513074/ https://www.ncbi.nlm.nih.gov/pubmed/33046677 http://dx.doi.org/10.4014/jmb.2008.08027 |
work_keys_str_mv | AT jinxing undecanoicacidlauricacidandntridecanoicacidinhibitescherichiacolipersistenceandbiofilmformation AT zhoujiacheng undecanoicacidlauricacidandntridecanoicacidinhibitescherichiacolipersistenceandbiofilmformation AT richeygabriella undecanoicacidlauricacidandntridecanoicacidinhibitescherichiacolipersistenceandbiofilmformation AT wangmengya undecanoicacidlauricacidandntridecanoicacidinhibitescherichiacolipersistenceandbiofilmformation AT hongsungminchoi undecanoicacidlauricacidandntridecanoicacidinhibitescherichiacolipersistenceandbiofilmformation AT hongseokhoon undecanoicacidlauricacidandntridecanoicacidinhibitescherichiacolipersistenceandbiofilmformation |